In ovarian cancer, elevated levels of HOXB-AS3 indicated an adverse prognosis 41, 44, and HOXB-AS3 overexpression is linked to higher histological grade, advanced FIGO stage, and lymph node metastasis in patients 44. The gene discussed is HOXB-AS3; the disease is ovarian carcinoma.